e-learning
resources
ERJ
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Decreased muscle PPAR concentrations: a mechanism underlying skeletal muscle abnormalities in COPD?
Sathyapala S. A., Kemp P., Polkey M. I.
Source:
Eur Respir J 2007; 30: 191-193
Journal Issue:
August
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sathyapala S. A., Kemp P., Polkey M. I.. Decreased muscle PPAR concentrations: a mechanism underlying skeletal muscle abnormalities in COPD?. Eur Respir J 2007; 30: 191-193
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Decreased expression of genes involved in skeletal muscle oxidative metabolism in COPD patients with muscle wasting
Source: Annual Congress 2008 - Respiratory muscle pathophysiology
Year: 2008
Impaired coordination of skeletal muscle protein turnover signalling in sarcopenic COPD patients
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Altered muscle metabolism and muscle mass in patients with COPD
Source: International Congress 2017 – Neuromuscular consequences of respiratory diseases
Year: 2017
Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD
Source: Eur Respir J 2003; 22: 88-93
Year: 2003
Mitochondrial functional alterations in COPD locomotor muscle are independent of cachexia and fiber type shift
Source: International Congress 2014 – Pathophysiological mechanisms at different scales
Year: 2014
Hypoxia-induced muscle atrophy and impaired regulation of protein turnover are partially dependent on muscle glucocorticoid receptor signaling
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Muscle morphology, metabolism and muscle function: general principles
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=86
Year: 2003
Increased autophagy and reduced protein synthesis signaling are involved in pulmonary inflammation-induced skeletal muscle atrophy
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Impaired myogenesis in the quadriceps muscle of cachectic COPD patients
Source: International Congress 2014 – Respiratory pathophysiology: mechanisms of alteration of lung, respiratory and peripheral muscle function
Year: 2014
Reduced expression of peroxisome proliferator-activated receptors (PPARs) in skeletal muscle of patients with COPD
Source: Annual Congress 2006 - Respiratory muscles
Year: 2006
The association of vitamine D deficiency and skeletal muscle dysfunction in COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Impaired skeletal muscle kynurenine metabolism in patients with COPD
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Permeabilized skeletal muscle fiber technique: a tool to unravel energy metabolism dysfunction in myopathy during chronic lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 393s
Year: 2003
Features of skeletal muscle dysfunction in COPD patients with obesity
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Hypoxia induces differential acute and chronic adaptations in regulation of skeletal muscle protein turnover
Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation
Year: 2011
Skeletal muscle inflammatory markers in COPD patients with muscle wasting
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
The clinical impact of skeletal muscle dysfunction
Source: Annual Congress 2008 - PG3 - Respiratory physiology: respiratory and peripheral muscle function in health and disease
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept